Vanda Pharmaceuticals Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Vanda Pharmaceuticals Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2016 to Q4 2023.
  • Vanda Pharmaceuticals Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $18.3M, a 18.3% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $18.3M +$2.83M +18.3% Dec 31, 2023 10-K 2024-02-08
Q4 2022 $15.5M +$2.55M +19.7% Dec 31, 2022 10-K 2024-02-08
Q4 2021 $12.9M +$1.7M +15.2% Dec 31, 2021 10-K 2024-02-08
Q4 2020 $11.2M +$1.49M +15.3% Dec 31, 2020 10-K 2024-02-08
Q4 2019 $9.74M +$9.74M Dec 31, 2019 10-K 2023-02-09
Q3 2019 $9.7M Sep 30, 2019 10-Q 2019-11-07
Q4 2018 $0 $0 Dec 31, 2018 10-K 2022-02-24
Q4 2017 $0 $0 Dec 31, 2017 10-K 2021-02-11
Q4 2016 $0 Dec 31, 2016 10-K 2020-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.